This short review outlines the physiology of glucagon in vivo, with an emphasis on its neural control, the author's area of interest. Glucagon is secreted from alpha cells, which are a minority of the pancreatic islet. Anatomically, they are down stream from the majority islet beta cells. Beta-cell secretory products restrain glucagon secretion. Activation of the autonomic nerves, which innervate the islet, increases glucagon secretion.
Glucagon is secreted into the portal vein and thus has its major physiologic action at the liver to break down glycogen. Glucagon thereby maintains hepatic glucose production during fasting and increases hepatic glucose production during stress, including the clinically important stress of hypoglycemia. Three different mechanisms proposed to stimulate glucagon secreted during hypoglycemia are discussed: (1) a stimulatory effect of low glucose directly on the alpha cell, (2) withdrawal of an inhibitory effect of adjacent beta cells, and (3) a stimulatory effect of autonomic activation.
In type 1 diabetes (T1DM), increased glucagon secretion contributes to the elevated ketones and acidosis present in diabetic ketoacidosis (DKA). It also contributes to the hyperglycemia seen with or without DKA. The glucagon response to insulin-induced hypoglycemia is impaired soon after the development of T1DM. The mediators of this impairment include loss of beta cells and loss of sympathetic nerves from the autoimmune diabetic islet.
BoscoDArmanetMMorelPNiclaussNSgroiAMullerYDGiovannoniLParnaudGBerneyT. Unique arrangement of alpha- and beta-cells in human islets of Langerhans. Diabetes.2010; 59 (5): 1202–10.
2.
DingWGKimuraHFujimuraMFujimiyaM. Neuropeptide Y and peptide YY immunoreactivities in the pancreas of various vertebrates. Peptides.1997; 18 (10): 1523–9.
3.
LindsayTHHalvorsonKGPetersCMGhilardiJRKuskowskiMAWongGYMantyhPW. A quantitative analysis of the sensory and sympathetic innervation of the mouse pancreas. Neuroscience.2006; 137 (4): 1417–26.
4.
MeiQMundingerTOLernmarkATaborskyGJJr. Early, selective, and marked loss of sympathetic nerves from the islets of BioBreeder diabetic rats. Diabetes.2002; 51 (10): 2997–3002.
5.
TaborskyGJJrMeiQHackneyDJFiglewiczDPLeBoeufRMundingerTO. Loss of islet sympathetic nerves and impairment of glucagon secretion in the NOD mouse: Relationship to invasive insulitis. Diabetologia.2009; 52 (12): 2602–11.
6.
ArvidssonURiedlMEldeRMeisterB. Vesicular acetylcholine transporter (VAChT) protein: A novel and unique marker for cholinergic neurons in the central and peripheral nervous systems. J Comp Neurol.1997; 378 (4): 454–67.
7.
SchäferMKEidenLEWeiheE. Cholinergic neurons and terminal fields revealed by immunohistochemistry for the vesicular acetylcholine transporter. II. The peripheral nervous system. Neuroscience.1998; 84 (2): 361–76.
8.
RossiJSantamäkiPAiraksinenMSHerzigKH. Parasympathetic innervation and function of endocrine pancreas requires the glial cell line-derived factor family receptor alpha2 (GFRalpha2). Diabetes.2005; 54 (5): 1324–30.
9.
MeiQBornfeldtKHackneyDMundingerTTaborskyGJJr. Neural selectivity in the loss of autonomic nerves from the islets of animal models of type 1 diabetes: Implications for mechanism. Diabetes.2010; 59 (Suppl 1): A210.
10.
MarlissEBGirardierLSeydouxJWollheimCBKanazawaYOrciLRenoldvAEPorteDJr. Glucagon release induced by pancreatic nerve stimulation in the dog. J Clin Invest.1973; 52 (5): 1246–59.
11.
AhrénBVeithRCTaborskyGJJr. Sympathetic nerve stimulation versus pancreatic norepinephrine infusion in the dog: 1) Effects on basal release of insulin and glucagon. Endocrinology.1987; 121 (1): 323–31.
12.
AhrénBTaborskyGJJr. The mechanism of vagal nerve stimulation of glucagon and insulin secretion in the dog. Endocrinology.1986; 118 (4): 1551–7.
13.
HavelPJVeithRCDunningBETaborskyGJJr. Pancreatic noradrenergic nerves are activated by neuroglucopenia but not hypotension or hypoxia in the dog. Evidence for stress-specific and regionally selective activation of the sympathetic nervous system. J Clin Invest., 1988; 82 (5): 1538–45.
HavelPJMundingerTOTaborskyGJJr. Pancreatic sympathetic nerves contribute to increased glucagon secretion during severe hypoglycemia in dogs. Am J Physiol.1996; 270 (1 Pt 1): E20–6.
16.
PatelDG. Role of parasympathetic nervous system in glucagon response to insulin-induced hypoglycemia in normal and diabetic rats. Metabolism.1984; 33 (12): 1123–7.
17.
GerichJDavisJLorenziMRizzaRBohannonNKaramJLewisSKaplanRSchultzTCryerP. Hormonal mechanisms of recovery from insulin-induced hypoglycemia in man. Am J Physiol.1979; 236 (4): E380–5.
18.
GerichJELangloisMNoaccoCKaramJHForshamPH. Lack of glucagon response to hypoglycemia in diabetes: Evidence for an intrinsic pancreatic alpha cell defect. Science.1973; 182 (108): 171–3.
19.
MojsovSHeinrichGWilsonIBRavazzolaMOrciLHabenerJF. Preproglucagon gene expression in pancreas and intestine diversifes at the level of post-translational processing. J Biol Chem.1986; 261 (25): 11880–9.
20.
MojsovSWeirGCHabenerJF. Insulinotropin: Glucagon-like peptide I (7–37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest.1987; 79 (2): 616–9.
21.
DruckerDJErlichPAsaSLBrubakerPL. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci USA.1996; 93 (15): 7911–6.
ExtonJH. Glucagon signal-transduction mechanisms. In: JeffersonLSCherringtonADGoodmanHM, ed. Handbook of physiology. New York: Oxford University Press; 2001, 435–50.
24.
CherringtonADLiljenquistJEShulmanGIWilliamsPELacyWW. Importance of hypoglycemia-induced glucose production during isolated glucagon deficiency. Am J Physiol.1979; 236 (3): E263–71.
25.
LiljenquistJEMuellerGLCherringtonADKellerUChiassonJLPerryJMLacyWWRabinowitzD. Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man. J Clin Invest.1977; 59 (2): 369–74.
26.
JensenMDCarusoMHeilingVMilesJM. Insulin regulation of lipolysis in nondiabetic and IDDM subjects. Diabetes.1989; 38 (12): 1595–601.
27.
KettelhutICWingSSGoldbergAL. Endocrine regulation of protein breakdown in skeletal muscle. Diabetes Metab Rev.1988; 4 (8): 751–72.
28.
WadaMConnollyCCTarumiCNealDWCherringtonAD. Hepatic denervation does not significantly change the response of the liver to glucagon in conscious dogs. Am J Physiol.1995; 268 (2 Pt 1): E194–203.
29.
DeFronzoRAFerranniniEHendlerRWahrenJFeligP. Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange. Proc Natl Acad Sci USA.1978; 75 (10): 5173–7.
30.
CherringtonADChiassonJLLiljenquistJEJenningsASKellerULacyWW. The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog. J Clin Invest.1976; 58 (6): 1407–18.
31.
DobbinsRLDavisSNNealDCaumoACobelliCCherringtonAD. Rates of glucagon activation and deactivation of hepatic glucose production in conscious dogs. Metabolism.1998; 47 (2): 135–42.
32.
GerichJECharlesMAGrodskyGM. Characterization of the effects of arginine and glucose on glucagon and insulin release from the perfused rat pancreas. J Clin Invest.1974; 54 (4): 833–41.
WeirGCKnowltonSDAtkinsRFMcKennanKXMartinDB. Glucagon secretion from the perfused pancreas of streptozotocin-treated rats. Diabetes.1976; 25 (4): 275–82.
36.
WendtABirnirBBuschardKGromadaJSalehiASewingSRorsmanPBraunM. Glucose inhibition of glucagon secretion from rat alpha-cells is mediated by GABA released from neighboring beta-cells. Diabetes.2004; 53 (4): 1038–45.
37.
ZhouHZhangTHarmonJSBryanJRoberstonRP. Zinc, not insulin, regulates the rat alpha-cell response to hypoglycemia in vivo. Diabetes.2007; 56 (4): 1107–12.
38.
TominagaMMaruyamaHVaskoMRBaetensDOrciLUngerRH. Morphologic and functional changes in sympathetic nerve relationships with pancreatic alpha-cells after destruction of beta-cells in rats. Diabetes.1987; 36 (3): 365–73.
39.
BolliGDe FeoPPerrielloGDe CosmoSCompagnucciPSanteusanioFBrunettiPUngerR. Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia. J Clin Invest.1984; 73 (4): 917–22.
40.
RajuBCryerPE. Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes: Documentation of the intraislet insulin hypothesis in humans. Diabetes.2005; 54 (3): 757–64.
41.
BanarerSMcGregorV PCryerPE. Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response. Diabetes.2002; 51 (4): 958–65.
42.
BloomSREdwardsAV. Pancreatic endocrine responses to stimulation of the peripheral ends of the vagus nerves in conscious calves. J Physiol.1981; 315: 31–41.
43.
GerichJEKaramJHForshamPH. Stimulation of glucagon secretion by epinephrine in man. J Clin Endocrinol Metab.1973; 37 (3): 479–81.
44.
DunningBEScottMFNealDWCherringtonAD. Direct quantification of norepinephrine spillover and hormone output from the pancreas of the conscious dog. Am J Physiol.1997; 272 (5 Pt 1): E746–55.
45.
TaborskyGJJrPaquetteTLPfeiferMAGingerichRL. Pentobarbital suppresses basal and reflexive pancreatic polypeptide release in dogs. Am J Physiol.1985; 249 (6 Pt 1): E577–83.
46.
CannonWBMcIverMABlissSW. Studies on the condition of activity in endocrine glands. XIII. A sympathetic and adrenal mechanism for mobilizing sugar in hypoglycemia. Am J Physiol.1924; 69: 46–66.
47.
GarberAJCryerPESantiagoJVHaymondMWPagliaraASKipnisDM. The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. J Clin Invest.1976; 58 (1): 7–15.
48.
HavelPJAkpanJOCurryDLSternJSGingerichRLAhrenB. Autonomic control of pancreatic polypeptide and glucagon secretion during neuroglucopenia and hypoglycemia in mice. Am J Physiol.1993; 265 (1 Pt 2): R246–54.
49.
HavelPJParrySJSternJSAkpanJOGingerichRLTaborskyGJJrCurryDL. Redundant parasympathetic and sympathoadrenal mediation of increased glucagon secretion during insulin-induced hypoglycemia in conscious rats. Metabolism.1994; 43 (7): 860–6.
50.
HavelPJVeithRCDunningBETaborskyGJJr. Role for autonomic nervous system to increase pancreatic glucagon secretion during marked insulin-induced hypoglycemia in dogs. Diabetes.1991; 40 (9): 1107–14.
51.
HavelPJValverdeC. Autonomic mediation of glucagon secretion during insulin-induced hypoglycemia in rhesus monkeys. Diabetes.1996; 45 (7): 960–6.
52.
BorgWPDuringMJSherwinRSBorgMABrinesMLShulmanGI. Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia. J Clin Invest.1994 Apr; 93 (4): 1677–82.
53.
McCrimmonRJSongZChengHMcNayECWeikart-YeckelCFanXRouthVHSherwinRS. Corticotrophin-releasing factor receptors within the ventromedial hypothalamus regulate hypoglycemia-induced hormonal counterregulation. J Clin Invest.2006; 116 (6): 1723–30.
54.
ParanjapeSAChanOZhuWHorblittAMMcNayECCresswellJABoganJSMcCrimmonRJSherwinRS. Influence of insulin in the ventromedial hypothalamus on pancreatic glucagon secretion in vivo. Diabetes.2010; 59 (6): 1521–7.
55.
BiggersDWMyersSRNealDStinsonRCooperNBJaspanJBWilliamsPECherringtonADFizzellRT. Role of brain in counterregulation of insulin-induced hypoglycemia in dogs. Diabetes.1989; 38 (1): 7–16.
56.
BorgMASherwinRSBorgWPTamborlaneWVShulmanGI. Local ventromedial hypothalamus glucose perfusion blocks conterregulation during systemic hypoglycemia in awake rats. J Clin Invest.1997; 99 (2): 361–5.
57.
HellerSRCryerPE. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes.1991; 40 (2): 223–6.
58.
HavelPJAhrenB. Activation of autonomic nerves and the adrenal medulla contributes to increased glucagon secretion during moderate insulin-induced hypoglycemia in women. Diabetes.1997; 46 (5): 801–7.
59.
MüllerWAFaloonaGRUngerRH. Hyperglucogonemia in diabetic ketoacidosis. Its prevalence and significance. Am J Med.1973; 54 (1): 52–7.
60.
UngerRHOrciL. Role of glucagon in diabetes. Arch Intern Med.1977; 137 (4): 482–91.
61.
GreenbaumCJHavelPJTaborskyGJJrKlaffLJ. Intra-islet insulin permits glucose to directly suppress pancreatic A cell function. J Clin Invest.1991; 88 (3): 767–73.
62.
BolliGDe FeoPCompagnucciPCartechiniMGAngelettiGSanteusanioFBrunettiPGerichJE. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes.1983; 32 (2): 134–41.
63.
AsplinCMPaquetteTLPalmerJP. In vivo inhibition of glucagon secretion by paracrine beta cell activity in man. J Clin Invest.1981; 68 (1): 314–8.
64.
CaprioSTamborlaneWVZychKGerowKSherwinRS. Loss of potentiating effect of hypoglycemia on the glucagon response to hyperaminoacidemia in IDDM. Diabetes.1993; 42 (4): 550–5.
65.
WiethopBVCryerPE. Glycemic actions of alanine and terbutaline in IDDM. Diabetes Care.1993; 16 (8): 1124–30.
66.
RossettiPPorcellatiFRicciN BusciantellaCandeloroPCioliPNairKSSanteusanioFBolliGBFanelliCG. Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people. Diabetes.2008; 57 (7): 1905–17.
67.
FukudaMTanakaATaharaYIkegamiHYamamotoYKumaharaYShimaK. Correlation between minimal secretory capacity of pancreatic beta-cells and stability of diabetic control. Diabetes.1988; 37 (1): 81–8.
68.
SegelSAParamoreDSCryerPE. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes.2002; 51 (3): 724–33.
69.
CooperbergBCryerPE. Insulin reciprocally regulates glucagon secretion in humans. Diabetes. 2010. Epub ahead of print.
70.
ZhouHTranPOYangSZhangTLeRoyEOseidERobertsonR P. Regulation of alpha-cell function by the beta-cell during hypoglycemia in Wistar rats: The “switch-off” hypothesis. Diabetes.2004; 53 (6): 1482–7.
71.
MonteggiaLMBarrotMPowellCMBertonOGalanisVGemelliTMeuthSNagyAGreeneRWNestlerEJ. Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc Natl Acad Sci USA.2004; 101 (29): 10827–32.
72.
MeiQBornfeldtKETaborskyGJJr. Loss of islet sympathetic nerves in a virally induced mouse model of autoimmune diabetes: Implications for mechanisms. Diabetes.2009; 58 (Suppl 1): A35.
73.
MeiQFoulisAKFlignerCHullRGilliamLTaborskyGJJr. Selective loss of sympathetic nerves from the islet in human type 1 diabetes: A potential mechanism for impaired glucagon responses to hypoglycemia. Diabetes.2006a; 55: A15.
74.
HoeldtkeRDBodenG. Epinephrine secretion, hypoglycemia unawareness, and diabetic autonomic neuropathy. Ann Intern Med.1994; 120 (6): 512–7.
75.
CryerPE. Hypoglycemia begets hypoglycemia in IDDM. Diabetes.1993; 42 (12): 1691–3.
76.
DavisSNShaversCCostaFMosqueda-GarciaR. Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans. J Clin Invest.1996; 98 (3): 680–91.
